Dataroma Value Investing
Real Time Insider Transaction Data

Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data

Selection Criteria
Timeframe :


Minimum transaction amount: $
Symbol watch list: (max. 15)
Total Transactions Amount
Buys 5 $2,694,633
Sells 22 $2,770,758
Filing▲▼
Symbol▲▼
 Security Reporting Name Relationship
Trans. Date▲▼
 Purchase/Sale Shares Price $
Amount $▲▼
 D/I
13 Jan 2025 16:06 FATE FATE THERAPEUTICS INC BRESSI JEROME CHARLES See Remarks 10 Jan 2025 Sale 5,980 1.55 9,269 D
13 Jan 2025 16:05 FATE FATE THERAPEUTICS INC TAHL CINDY See Remarks 10 Jan 2025 Sale 5,654 1.55 8,764 D
13 Jan 2025 16:04 FATE FATE THERAPEUTICS INC VALAMEHR BAHRAM President and CEO 10 Jan 2025 Sale 8,705 1.54 13,406 D
26 Dec 2024 21:00 FATE FATE THERAPEUTICS INC REDMILE GROUP, LLC Director , 10% 20 Dec 2024 Sale 341,633 1.68 573,943 I
26 Dec 2024 21:00 FATE FATE THERAPEUTICS INC REDMILE GROUP, LLC Director , 10% 20 Dec 2024 Purchase 397,964 1.68 668,580 I
07 Aug 2024 16:01 FATE FATE THERAPEUTICS INC XU YUAN Director 06 Aug 2024 Sale 633 4.23 2,678 D
05 Mar 2024 16:24 FATE FATE THERAPEUTICS INC DULAC EDWARD J III Chief Financial Officer 04 Mar 2024 Sale 2,447 7.77 19,013 D
30 Jan 2024 16:01 FATE FATE THERAPEUTICS INC DULAC EDWARD J III Chief Financial Officer 29 Jan 2024 Sale 1,849 5 9,245 D
10 Jan 2024 16:30 FATE FATE THERAPEUTICS INC TAHL CINDY General Counsel and Secretary 09 Jan 2024 Sale 10,874 4.37 47,519 D
10 Jan 2024 16:30 FATE FATE THERAPEUTICS INC VALAMEHR BAHRAM Chief R&D Officer 09 Jan 2024 Sale 11,271 4.38 49,367 D
10 Jan 2024 16:29 FATE FATE THERAPEUTICS INC WOLCHKO J SCOTT President and CEO 09 Jan 2024 Sale 14,391 4.37 62,889 D
10 Jan 2024 16:29 FATE FATE THERAPEUTICS INC DULAC EDWARD J III Chief Financial Officer 09 Jan 2024 Sale 7,028 4.37 30,712 D
03 Jan 2024 16:03 FATE FATE THERAPEUTICS INC DULAC EDWARD J III Chief Financial Officer 02 Jan 2024 Sale 5,182 3.66 18,966 D
28 Dec 2023 21:30 FATE FATE THERAPEUTICS INC REDMILE GROUP, LLC Director , 10% 26 Dec 2023 Purchase 44,630 3.72 166,024 I
19 Dec 2023 16:01 FATE FATE THERAPEUTICS INC DULAC EDWARD J III Chief Financial Officer 18 Dec 2023 Sale 1,585 3.5 5,548 D
13 Nov 2023 16:01 FATE FATE THERAPEUTICS INC TAHL CINDY General Counsel and Secretary 09 Nov 2023 Sale 24,363 2.4 58,471 D
21 Aug 2023 16:02 FATE FATE THERAPEUTICS INC DULAC EDWARD J III Chief Financial Officer 18 Aug 2023 Sale 4,718 2.8 13,210 D
07 Aug 2023 16:01 FATE FATE THERAPEUTICS INC XU YUAN Director 04 Aug 2023 Sale 632 3.71 2,345 D
06 Jul 2023 17:19 FATE FATE THERAPEUTICS INC POWL BRIAN T. Chief Commercial Officer 05 Jul 2023 Sale 3,854 4.87 18,769 D
06 Jul 2023 17:18 FATE FATE THERAPEUTICS INC DULAC EDWARD J III Chief Financial Officer 05 Jul 2023 Sale 5,182 4.83 25,029 D
15 Jun 2023 16:05 FATE FATE THERAPEUTICS INC XU YUAN Director 14 Jun 2023 Sale 3,460 5.58 19,307 D
21 Apr 2023 21:55 FATE FATE THERAPEUTICS INC REDMILE GROUP, LLC Director , 10% 21 Apr 2023 Purchase 256,639 6.18 1,586,029 I
21 Apr 2023 21:55 FATE FATE THERAPEUTICS INC REDMILE GROUP, LLC Director , 10% 20 Apr 2023 Purchase 20,000 5.99 119,800 I
19 Apr 2023 16:07 FATE FATE THERAPEUTICS INC CHU YU-WAYE Chief Medical Officer 18 Apr 2023 Sale 2,317 6.58 15,246 D
19 Apr 2023 16:07 FATE FATE THERAPEUTICS INC CHU YU-WAYE Chief Medical Officer 18 Apr 2023 Sale 215 6.52 1,402 D
17 Apr 2023 21:30 FATE FATE THERAPEUTICS INC REDMILE GROUP, LLC Director , 10% 14 Apr 2023 Purchase 25,700 6 154,200 I
17 Apr 2023 21:30 FATE FATE THERAPEUTICS INC REDMILE GROUP, LLC Director , 10% 14 Apr 2023 Sale 302,339 5.84 1,765,660 I

* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)